1174O - Prognostic and Predictive Roles of Egfr Copy Number and Kras Mutation Status from the Radiant Trial of Adjuvant Erlotinib (E) Versus Placebo (P)
| Autor: | Shepherd, F.A., Altorki, N.K., Eberhardt, W.E.E., O'Brien, M.E.R., Wang, J., Horan, J.D., Foley, M.A., Iwata, K.K., Gill, S.C., Richardson, F.C., Kelly, K. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:iv409-iv409 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|